Factors prognostic of OS in patients with HCC undergoing TACE include tumor size, tumor multiplicity, vascular invasion, extrahepatic spread, underlying liver functional reserve, α-fetoprotein (AFP) concentration, and performance status [3,4,5,6]. This evidence concerns the gene AFP and neoplasm.